Abiopharma

Moleculin Issues New Positive AML Overall Survival Data:

New Form 6-K - Alpha Tau Medical Ltd. Filed: 2025-08-27 AccNo: 0001213900-25-080928 Size: 35 KB

Disc Medicine to Participate in Upcoming Investor Conferences

Liquidia Corporation to Present at the 2025 Wells Fargo Healthcare Conference

Zoetis - Zoetis to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

Schrödinger, Inc. - Schrödinger to Present at Morgan Stanley Global Healthcare Conference

FibroBiologics to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Lexicon Pharmaceuticals to Participate at Two Upcoming Investor Conferences

Hawkins, Inc. to Participate in Sidoti & Company’s Small Cap Virtual Investor Conference

Allogene Therapeutics Announces Participation in Upcoming Investor Conference

Zoetis to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

Alpha Tau to Participate in Five September Investor Conferences

Other Scheme of Arrangement: ADJOURNMENT OF THE SCHEME MEETING TO BE CONVENED ON 28 AUGUST 2025 AT 2.00 P.M.

Director Hertz Walter Marc 🟢 acquired 26.7K shares (1 derivative) of GRI Bio, Inc. (GRI) at $1.41 Transaction Date: Aug 26, 2025 | Filing ID: 000144

Director SIMPSON CAMILLA V 🟢 acquired 6.0K shares (1 derivative) of GRI Bio, Inc. (GRI) at $1.41 Transaction Date: Aug 26, 2025 | Filing ID: 000139